Distinguished in Age-Related Macular Degeneration (ARMD)

Se W. Kang

Seoul, KR 
Distinguished in Age-Related Macular Degeneration (ARMD)
Seoul, KR 
OverviewLocationsClinical Research

Overview

Se Kang practices in Seoul, Republic of Korea. Kang is rated as a Distinguished expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Their top areas of expertise are Age-Related Macular Degeneration (ARMD), Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

Their clinical research consists of co-authoring 131 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 36 articles in the study of Age-Related Macular Degeneration (ARMD).

Locations

Seoul, Republic of Korea
Other Locations
Changwon, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized Controlled Trial to Evaluate Effect of a Structured Rehabilitation Exercise Program on Facedown Posture-related Pain After Retinal Surgery
A Randomized Controlled Trial to Evaluate Effect of a Structured Rehabilitation Exercise Program on Facedown Posture-related Pain After Retinal Surgery
Enrollment Status: Completed
Publish Date: December 16, 2020
Intervention Type: Behavioral
Study Phase: Not Applicable
Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy
Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy
Enrollment Status: Completed
Publish Date: September 05, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

131 Total Publications

Reply to Comment on: COVID-19 Vaccination and Ocular Adverse Events: A Self-Controlled Case Series Study From the Entire South Korean Population.
Reply to Comment on: COVID-19 Vaccination and Ocular Adverse Events: A Self-Controlled Case Series Study From the Entire South Korean Population.
Journal: American journal of ophthalmology
Published: April 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kang's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile